Eyenovia Inc. (EYEN)
Symbol Info
Listed Symbol EYEN
Name Eyenovia Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-1.83
Price Info
21 Day Moving Average $3.6733
21 Day EMA $3.516970
50 Day Moving Average $3.6326
50 Day EMA $3.667720
200 Day EMA $4.325600
200 Day Moving Average 4.397360
52 Week High $6.98
52 Week Low $2.40
52 Week Change $-20.263199
Alpha -0.044453
Beta 1.1199
Standard Deviation 0.171031
R2 0.079504
Periods 21
Share Information
10 Day Average Volume 72,123
20 Day Average Volume 90,129
30 Day Average Volume 100,380
50 Day Average Volume 74,664
Outstanding Shares 17,100,726
Float Shares 14,974,403
Percent Float 87.57%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 30
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 163,073
Institute Holdings Percent 9.200000
Institute Sold Previous 3 Months 131,029
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 20
Insider Holdings Percent 12.40%
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,126,323
Price Change
7 Day Price Change $-0.29
7 Day Percent Change -8.73%
21 Day Price Change $-0.97
21 Day Percent Change -24.25%
30 Day Price Change $-1.8799999
30 Day Percent Change -38.29%
Month To Date Price Change $-0.67
Month To Date Percent -18.11%
90 Day Price Change $-0.15
90 Day Percent Change -4.72%
Quarter To Date $-0.67
Quarter To Date Percent -18.11%
180 Day Price Change $-3.49
180 Day Percent Change -53.53%
200 Day Price Change $-2.96
200 Day Percent Change -49.42%
Year To Date $0.180000
Year To Date Percent 6.32%
Profile
Description Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.
Details
Issue Type CS
Market Cap $51,815,200
Sec Type
Auditor Marcum LLP
Total Shares Outstanding 17,100,726
CEO Tsontcho Ianchulev
Employees 22
Last Audit UQ
Classification
CIK 0001682639
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 295 Madison Avenue
Suite 2400
New York, NY 10017
Website https://www.eyenoviabio.com
Facisimile
Telephone +1 917 289-1117
Email admin@eyenoviabio.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $54,033,077
Price To Sales -
Price To Free Cash -3.8
PE High Last 5 Years -
Price To Book 7.5
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 7.5
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 4.1
Leverage Ratio 1.4
Quick Ratio 3.9
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -124.91
Return On Equity -139.73
Return On Capital -139.73
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
EYEN
Eyenovia
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.